[Serious form of Schultz' agranulocytosis in a 3-year-old child].
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000380:Agranulocytosis / Q000139:chemically induced* / Q000188:drug therapy; D000632:Aminopyrine / Q000009:adverse effects*; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D000935:Antifungal Agents / Q000627:therapeutic use; D002675:Child, Preschool; D003298:Coombs Test; D003875:Drug Eruptions / Q000209:etiology; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use
D000906:Antibodies; D000935:Antifungal Agents; D000632:Aminopyrine; D000324:Adrenocorticotropic Hormone; D011241:Prednisone
Schwerste Form der Schultz-Agranulozytose bei einem dreijährigen Kinde.